Whole genome sequence data of strain TM10, a plant growth-promoting fungus and biocontrol agent.

strain TM10 was isolated from rhizosphere soil of rice plants cultivated under system of rice intensification (SRI) practises in West Java, Indonesia. It exhibits significant potential as a plant growth promoter and biocontrol agent in rice plants. Although this strain has shown promise in promoting plant growth and suppressing phytopathogens under and conditions, there is still a lack of genomic data to elucidate the molecular mechanisms underlying its plant growth-promoting and biocontrol capabilities.

Medication stewardship in the operating theatre in Malaysia: A quality improvement project.

Background And Aims: A quality improvement project ('Safe Anaesthesia for ALL-SEAL') was implemented to reduce preventable medication errors and drug wastage in the operating theatre (OT) of a tertiary hospital. The primary objective of this quality improvement project was to prevent the incidence of medication errors, and the secondary objective was to reduce the wastage of unused drugs.

Methods: A pre-intervention questionnaire and an audit survey were performed, and multidirectional interventions were designed post-survey.

Characterization of four novel actinospore types of fish parasitic myxozoans and the occurrence of and from fish farms of Hungary.

Six distinct actinospore types were identified in the intestinal epithelium of oligochaetes collected from the Szigetbecse and Makád fish farms of Ráckeve Danube Arm Fishing Association, in Hungary. Four new types: triactinomyxon type, raabeia type, aurantiactinomyxon type 1, and aurantiactinomyxon type 2, were described morphologically and molecularly from three invertebrate host species: , and . The 18S ribosomal DNA (rDNA) analysis revealed that these new types of actinospores did not match any myxospore sequences available in GenBank.

Immunogenicity of monoclonal antibody: Causes, consequences, and control strategies.

Antibody-based treatment was first used in 1891 for the treatment of diphtheria. Since then, monoclonal antibodies (mAbs) have been developed to treat many diseases such as cancer and act as vaccines. However, murine-derived therapeutic mAbs were found to be highly immunogenic, and caused anti-drug antibodies (ADAs) reaction, reducing their efficacy and causing severe infusion reactions.